1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Anaphylaxis in 212 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 80 (37.74) | 18.7374 |
1990's | 60 (28.30) | 18.2507 |
2000's | 29 (13.68) | 29.6817 |
2010's | 32 (15.09) | 24.3611 |
2020's | 11 (5.19) | 2.80 |
Authors | Studies |
---|---|
Adeli, K; Du, YJ; Eiwegger, T; Finkelstein, Y; Grunebaum, E; Hoang, JA; Leon-Ponte, M; Upton, JEM; Vadas, P | 1 |
Ebina, K; Fukase, T; Sato, A | 1 |
Grunebaum, E; Sussman, G; Upton, JEM; Vadas, P | 1 |
Abas, F; Israf, DA; Khoo, LW; Kow, ASF; Lee, MT; Shaari, K; Tan, JW; Tham, CL | 1 |
Abo, H; Akita, H; Arai, T; Hatakeyama, H; Hirakawa, J; Hisaka, A; Kawashima, H; Kokubo, T; Tang, R; Terui, A | 1 |
Kukkonen, K; Mäkelä, MJ; Röntynen, P; Savinko, T | 1 |
Kuda, Y; Kurata, Y; Ono, M; Shibamoto, T; Tanida, M | 1 |
Ballesteros-Martinez, C; Beitia, JM; Blanco-Colio, LM; Cuesta-Herranz, J; Díaz-Perales, A; Esteban, V; Garrido-Arandia, M; Gutiérrez-Muñoz, C; Jensen, BM; Laguna, JJ; Mendez-Barbero, N; Nuñez-Borque, E; Poulsen, LK; Tome-Amat, J; Yuste-Montalvo, A | 1 |
Galli, SJ | 1 |
Bruhns, P; Chollet-Martin, S | 1 |
Chciałowski, A; Juszkiewicz, A; Korsak, JŁ; Kruszewski, J; Piwowarek, KŁ; Rzeszotarska, A | 1 |
Hasegawa, A; Ogawa, M; Ohmori, K; Ohno, H; Osada, H; Sasaki, K; Shimoda, M; Shirai, J; Watanabe, M; Yanuma, N | 1 |
Bodzenta-Łukaszyk, A; Klimek, M; Lis, A; Moniuszko, M; Tomasiak-Łozowska, MM | 1 |
Cardona, V; Guilarte, M; Sala-Cunill, A | 1 |
Baretto, RL; Beck, SC; Buka, RJ; Huissoon, AP; Krishna, MT; Wilding, T | 1 |
Aubier, M; Bay, S; Bruhns, P; Chollet-Martin, S; Cholley, B; de Chaisemartin, L; Dib, F; Fischler, M; Ganneau, C; Gillis, CM; Gouel-Chéron, A; Granger, V; Guinnepain, MT; Hurtado-Nedelec, M; Jacob, L; Jönsson, F; Keita-Meyer, H; Langeron, O; Le Dorze, M; Longrois, D; Montravers, P; Necib, S; Neukirch, C; Nicaise-Roland, P; Paugam-Burtz, C; Plaud, B; Sauvan, C; Tubach, F; Zhu, Q | 1 |
Bongrand, P; Vitte, J | 1 |
Vadas, P | 2 |
Asano, M; Cui, H; Du, W; Okamoto, Y; Shibamoto, T; Takuwa, N; Takuwa, Y; Yoshioka, K; Zhang, W | 1 |
Gong, F; Katirai, F; Li, D; Xiong, P; Xu, Y; Yang, Y; Zhang, B; Zheng, F | 1 |
Montagni, M; Parente, R; Ridolo, E; Triggiani, M | 1 |
Kuda, Y; Kurata, Y; Shibamoto, T; Tanida, M; Wang, M | 1 |
Gill, P; Jagdis, A; Jindal, NL; Vadas, P | 1 |
Cardona, V; Sala-Cunill, A | 1 |
Bartuzi, Z; Pałgan, K | 1 |
Kuda, Y; Kurata, Y; Shibamoto, T; Song, J; Tanida, M; Wang, M; Zhang, T | 1 |
Farbman, KS; Michelson, KA | 1 |
Bae, YS; Im, SY; Kim, HK; Lee, HK; Song, CH | 1 |
Cui, S; Kurata, Y; Liu, W; Shibamoto, T; Takano, H; Zhang, W | 1 |
Aosai, F; Fang, H; Kikumura, A; Mun, HS; Norose, K; Sayama, Y; Yano, A | 1 |
Finkelman, FD; Herbert, DR; Hogan, S; Karasuyama, H; Khodoun, M; Köhl, J; Orekov, T; Strait, R | 1 |
Karasuyama, H; Mukai, K; Obata, K; Tsujimura, Y | 2 |
Boon, L; Galli, SJ; Mantegazza, R; Musio, S; Ohtsu, H; Pedotti, P; Pedotti, R; Steinman, L | 1 |
Incorvaia, C; Incorvaia, S; Mauro, M; Pravettoni, V; Riario-Sforza, GG | 1 |
Bradding, P; Cruse, G; Kajiwara, N; Ohmori, K; Okayama, Y; Ra, C; Sagara, H; Saito, H; Sasaki, T | 1 |
Ferrer, M; Gamboa, PM; García-Figueroa, BE; Sanz, ML | 1 |
Bruhns, P; Daëron, M; Iannascoli, B; Jönsson, F; Karasuyama, H; Kita, Y; Mancardi, DA; Shimizu, T; Van Rooijen, N | 1 |
Han, MK; Hwang, PH; Im, SY; Kang, NI; Kim, HA; Kim, KJ; Lee, HK; Lee, YR; Shin, SJ; Soh, BY; Yoon, HY | 1 |
Kemp, SF; Khan, BQ | 1 |
Endo, Y; Kuroishi, T; Nagai, Y; Sugawara, S; Tanaka, Y | 1 |
Fiechter, D; Hassing, I; Leusen, JH; Pennings, M; Pieters, RH; Smit, JJ; Storm, G; van Bloois, L; Willemsen, K; Zaiss, D | 1 |
Perelman, B; Vadas, P | 1 |
Gao, CR; Guo, XJ; Yan, XB; Yang, K | 1 |
Liss, G; Perelman, B; Vadas, P | 1 |
Hirayama, F | 1 |
Merk, HF; Vanstreels, L | 1 |
Finkelman, FD; Morris, SC; Smiley, K; Strait, RT; Urban, JF | 1 |
Choi, IW; Choi, JH; Ha, TY; Im, SY; Kim, DK; Kim, YS; Kwon, KS; Lee, HK; Lee, MS; Seo, KH | 1 |
Brandt, EB; Finkelman, FD; Hershko, D; Muntel, EE; Rothenberg, ME; Scribner, TA; Strait, RT; Wang, Q; Zimmermann, N | 1 |
Fallon, PG; Fallon, RE; Mangan, NE; McKenzie, AN; Smith, P; van Rooijen, N | 1 |
Iinuma, M; Ishiguro, K; Oku, H; Ueda, Y | 1 |
Choi, IH; Choi, IW; Chung, WC; Kang, NI; Kim, YS; Lee, HK; Song, CH; Woo, HY | 1 |
Brouckaert, P; Buys, E; Cauwels, A; Janssen, B; Sips, P | 1 |
Ahmed, AK; Aosai, F; Fang, H; Furuya, M; Mun, HS; Norose, K; Yano, A | 1 |
Blyth, T; Cass, D; Gold, M; Lack, G; Liss, GM; Perelman, B; Simons, FE; Simons, KJ; Vadas, P; Yeung, J | 1 |
Burks, AW | 1 |
Jancar, S; Kwasniewski, FH; Landgraf, RG | 1 |
Karasuyama, H; Kawano, Y; Minegishi, Y; Mukai, K; Nishikado, H; Obata, K; Shimizu, T; Shindou, H; Tsujimura, Y; Yoshida, M | 1 |
Levy, JH | 1 |
Kamatani, N; Okamoto, H | 1 |
Bansal, AS; Chee, R; Sumar, N | 1 |
Franco, CB; Galli, SJ | 1 |
Kato, Y; Kremenik, MJ; Matsumoto, T; Shiva, D; Yano, H | 1 |
O'Flaherty, JT | 1 |
Bach, MK | 1 |
Benveniste, J; Bussolino, F | 1 |
O'Flaherty, JT; Wykle, RL | 1 |
Pinckard, RN | 1 |
Bergstrand, H; Dahlbäck, M; Sörenby, L | 1 |
Barth, T; Bekemeier, H; Hänsel, F; Hirschelmann, R; Sänze, JU | 1 |
Vargaftig, BB | 1 |
Burke, JA; Guo, ZG; Hanahan, DJ; Hattori, Y; Hoppens, CM; Levi, R; McManus, LM; Pinckard, RN | 1 |
Antro, C; Bussolino, F; Camussi, G; Emanuelli, G; Montrucchio, G; Tetta, C | 1 |
Bloor, CM; Hugli, TE; McCall, CE; O'Flaherty, JT; Stimler, NP; Wykle, RL | 1 |
Benveniste, J; Chignard, M; Lefort, J; Vargaftig, BB | 1 |
Demopoulos, CA; Kapoulas, VM; Tsabikakis, GE | 1 |
Halonen, M; Lohman, IC; McManus, LM; Palmer, JD; Pinckard, RN | 2 |
Halonen, M; Hanahan, DJ; McManus, LM; Pinckard, RN | 1 |
Davison, JS; Mathison, R | 1 |
Giessler, C; Heinroth-Hoffmann, I; Meissner, N; Mest, HJ; Pönicke, K | 1 |
Bindi, D; Franchi-Micheli, S; Gentilini, G; Mugnai, S; Zilletti, L | 1 |
Desquand, S; Hatmi, M; Lefort, J; Pina, M; Priego, JG; Ruffié, C; Vargaftig, BB | 1 |
Parnell, DW; Spellman, JM; Stephens, DJ; Yanni, JM | 1 |
Choi, IH; Ha, TY; Lee, DG; Lee, HK; Lee, JH; Park, JS; Park, YM | 1 |
Coffman, TM; Goulet, JL; Koller, BH; Latour, AM; Snouwaert, JN | 1 |
Almansa, C; Balsa, D; Bartrolí, J; Carceller, E; Forn, J; García-Rafanell, J; Giral, M; Merlos, M | 1 |
Furió, V; Pellón, MI; Sánchez Crespo, M; Steil, AA | 1 |
Dahlén, SE; Jonsson, EW | 1 |
Chen, XS; Funk, CD; Johnson, EN; Sheller, JR | 1 |
Kelefiotis, D; Vakirtzi-Lemonias, C | 1 |
Imanishi, N; Koike, H; Morooka, S; Murakami-Uchida, M; Natsume, Y | 1 |
Catto-Smith, AG; Gall, DG; Scott, RB; Tan, D | 1 |
Nishino, K; Ohashi, M; Uno, T | 1 |
Almansa, C; Bartrolí, J; Carceller, E; Forn, J; García-Rafanell, J; Giral, M; Merlos, M | 1 |
Halonen, M; Lohman, IC | 1 |
Amorim, CZ; Cordeiro, RS; Vargaftig, BB | 1 |
Kamiya, S; Kanda, M; Kurahashi, K; Matsui, H; Nakamura, S; Shirahase, H; Wada, K | 1 |
Byrum, RS; Goulet, JL; Griffiths, RJ; Koller, BH | 1 |
Akuta, K; Ichimura, M; Kase, H; Kawakita, T; Kawasaki, H; Kitamura, S; Manabe, H; Nukui, E; Ohmori, K; Sato, S; Sejimo, H; Suzuki, F | 1 |
Hellewell, PG; Kunkel, SL; Lukacs, NW; Proudfoot, AE; Teixeira, MM; Wells, TN; Williams, TJ | 1 |
Koyama, S; Miyahara, T; Shibamoto, T; Wang, HG | 1 |
Ikuta, K; Ishii, S; Komagata, Y; Kume, K; Maki, K; Miyazaki, J; Nagase, T; Nakatani, N; Ouchi, Y; Shimizu, T; Tashiro, F; Uozumi, N | 1 |
Chai, OH; Choi, IH; Ha, TY; Han, EH; Im, SY; Lee, HK; Lee, MS; Park, JS; Shin, YM | 1 |
Harada, M; Kimura, S; Nagata, M; Takeuchi, M; Watanabe, A | 1 |
Huh, H; Kim, HK; Lee, HK | 1 |
Ishii, S; Shimizu, T | 1 |
Ishiguro, K; Oku, H | 1 |
Byrum, RS; Goulet, JL; Griffiths, RJ; Koller, BH; Snouwaert, JN | 1 |
Fukuda, Y; Inomata, N; Kawashima, H; Matsui, M; Nakanishi, T; Saito, K | 1 |
Bock, CB; Haribabu, B; Sellars, DD; Snyderman, R; Steeber, DA; Verghese, MW | 1 |
Alloatti, G; Camussi, G; Montrucchio, G | 1 |
Akiyama, H; Goda, Y; Okunuki, H; Sakushima, J; Sawada, JI; Teshima, R; Toyoda, M | 1 |
Tibiriçá, E | 1 |
Makiyama, Y; Mitsui, Y; Tanaka, Y | 1 |
Finkelman, FD; Morris, SC; Qu, XW; Strait, RT; Yang, M | 1 |
Porsius, AJ; Vleeming, W; Wemer, J | 1 |
Desquand, S; Dumarey, C; Lefort, J; Vargaftig, BB | 2 |
Bozza, PT; Castro-Faria-Neto, HC; Cordeiro, RS; Lima, MC; Martins, MA; Silva, AR; Silva, PM; Vargaftig, BB | 1 |
Fisher, RA; Hines, KL | 1 |
Befus, AD; Davison, JS; Mathison, R | 1 |
Hibi, M; Iwama, T; Sakashita, M; Shikada, K; Tanaka, S; Yamamoto, A | 1 |
Fernández-Gallardo, S; Furio, V; García, C; Gijón, MA; Liu, FT; Sánchez Crespo, M | 1 |
Imanishi, N; Morooka, S; Uchida, M | 1 |
Amorim, CZ; Cordeiro, RS; Henriques, MG; Vargaftig, BB; Weg, VB | 1 |
Ahmad, Z; Baumann, G; Berdel, WE; Felix, SB; Hashemi, T; Niemczyk, M | 1 |
Imura, Y; Kawamura, M; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S | 1 |
Catto-Smith, AG; Gall, DG; MacNaughton, WK | 1 |
Braquet, P; Carrier, J; Jancar, S; Sirois, MG; Sirois, P | 1 |
Heuer, HO | 3 |
Harada, K; Katayama, K; Katayama, S; Muramoto, K; Sakuma, Y; Tsunoda, H | 1 |
Maric, M; Scott, RB | 1 |
Herbert, JM; Lespy, L; Maffrand, JP | 1 |
Imanishi, N; Morooka, S; Sugasawa, T; Uchida, M | 1 |
Arimura, A; Harada, M | 1 |
Fukuda, T; Makino, S | 1 |
Bertrand, C; Landry, Y; Tschirhart, E | 1 |
Harada, K; Katayama, S; Machida, Y; Miyazawa, S; Obaishi, H; Okano, K; Sakuma, Y; Shirato, M; Tsunoda, H; Yamada, K | 1 |
Aratani, H; Setoguchi, M; Tahara, T; Terasawa, M | 1 |
Egan, RW; Fernandez, X; Gulbenkian, AR; Kreutner, W; Kung, T; Minnicozzi, M; Watnick, AS | 1 |
Levi, R; Mullane, KM | 1 |
Arimura, A; Harada, M; Nagata, M; Nakamura, K; Takeuchi, M; Watanabe, A | 1 |
Halonen, M; Lohman, I | 1 |
Bosson, L; Damas, J; Leclercq, M; Lecomte, J | 1 |
Eyre, P; Ogunbiyi, PO | 1 |
Aoki, H; Kohsaka, M; Okamoto, M; Uchida, I; Yoshida, K | 1 |
Frei, PC; Pécoud, A | 1 |
Braquet, P; Cirino, M; Desquand, S; Lagente, V; Lefort, J; Randon, J; Touvay, C; Vargaftig, BB; Vilain, B | 1 |
Braquet, P; Desquand, S; Lagente, V; Lefort, J; Randon, J; Touvay, C; Vargaftig, BB; Vilain, B | 2 |
Braquet, P; Hosford, D; Mencia-Huerta, JM | 1 |
Gabryelewicz, A; Rydzewska, G | 1 |
Piper, PJ; Yaacob, HB | 1 |
Bachelet, M; Lefort, J; Lellouch-Tubiana, A; Pretolani, M; Vargaftig, BB | 1 |
Braquet, P; Koltai, M; Szekeres, L; Tosaki, A | 1 |
Marone, G | 1 |
Cordón-Cardó, C | 1 |
Makino, S | 1 |
Casals-Stenzel, J; Heuer, H | 2 |
Braquet, P; Colliez, P; Guilmard, C; Pirotzky, E | 1 |
Bahr, T; Becker, K; Förster, W; Grupe, R; Lueddeckens, G; Schaper, U; Scheuch, DW | 1 |
Fitzgerald, MF; Moncada, S; Parente, L | 2 |
Borgeat, P; Braquet, P; Harczy, M; Maclouf, J; Pradelles, P; Sirois, P | 2 |
Anderson, GP; Fennessy, MR; Stewart, AG | 1 |
Braquet, PG; Vargaftig, BB | 1 |
Braquet, P; Etienne, A; Taylor, JE; Touvay, C; Vilain, B | 1 |
Braquet, P | 1 |
Beauvais, F; Benveniste, J | 1 |
Ishii, H; Kase, H; Manabe, H; Ohmori, K; Satoh, H; Tamura, T | 1 |
Damas, J | 1 |
Imura, Y; Nishikawa, K; Sumida, S; Terashita, Z | 1 |
Biftu, T; Doebber, TW; Wu, MS | 1 |
Darius, H; Lefer, AM; Smith, JB | 1 |
Chavis, C; Crastes De Paulet, A; Damon, M; Godard, P; Michel, FB | 1 |
Darius, H; Lefer, AM; Lefer, DJ; Smith, JB | 1 |
Faden, AI; McIntosh, TK | 1 |
Berti, F; Braquet, P; Omini, C; Rossoni, G | 1 |
Imura, Y; Nishikawa, K; Shino, A; Terashita, Z | 1 |
Darius, H; Lefer, AM | 1 |
Hayashi, Y; Hirasawa, N; Ohuchi, K; Sugidachi, A; Tsurufuji, S; Watanabe, M | 1 |
Piper, PJ; Stewart, AG | 1 |
Bahr, T; Becker, K; Förster, W; Göres, E; Grupe, R; Lueddeckens, G; Schaper, U; Scheuch, DW | 1 |
Chapman, RW; Danko, G; Grissom, B; Kreutner, W; Sherwood, JE | 1 |
Berti, F; Magni, F; Rossoni, G | 1 |
Lefort, J; Lellouch-Tubiana, A; Pfister, A; Simon, MT; Vargaftig, BB | 1 |
Bourgain, RH; Braquet, P | 1 |
Braquet, P; Guinot, P; Touvay, C | 1 |
Cirino, M; Desquand, S; Lagente, V; Lefort, J; Vargaftig, BB | 1 |
Berti, F; Bongrani, S; Magni, F; Pasargiklian, R; Rossoni, G; Schiantarelli, P | 1 |
Peskar, BA; Simmet, T | 1 |
Moudgil, GC | 1 |
Lefort, J; Lellouch-Tubiana, A; Pfister, A; Vargaftig, BB | 1 |
Casals-Stenzel, J | 1 |
Angle, MJ; McManus, LM; Pinckard, RN; Showell, HJ | 1 |
Lefort, J; Malanchère, E; Pretolani, M; Vargaftig, BB | 1 |
Braquet, P; Etienne, A; Touvay, C | 1 |
Andersson, P; Brange, C; Chignard, M; Le Còuedic, JP | 1 |
Cirino, M; Lagente, V; Lefort, J; Vargaftig, BB | 1 |
Bessin, P | 1 |
Braquet, P; Chabrier, E; Koltai, M; Lepran, I; Szekeres, L; Viossat, I | 1 |
Baranès, J; Braquet, P; Fernández-Gallardo, S; Nieto, ML; Sánchez-Crespo, M | 1 |
Dunn, AM; Halonen, M; Lohman, IC; McManus, LM; Palmer, JD | 1 |
Detsouli, A; Lefort, J; Vargaftig, BB | 1 |
Clark, JS; Jubb, SN; Maloney, PJ; Young, JM | 1 |
41 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anaphylaxis
Article | Year |
---|---|
Platelet Activating Factor (PAF): A Mediator of Inflammation.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anaphylaxis; Animals; Child; Humans; Inflammation; Platelet Activating Factor | 2022 |
Mechanisms of human drug-induced anaphylaxis.
Topics: Anaphylaxis; Animals; Cell Degranulation; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Histamine; Humans; Immunoglobulin E; Immunoglobulin G; Mice; Platelet Activating Factor; Receptors, G-Protein-Coupled | 2021 |
Markers of anaphylaxis - a systematic review.
Topics: Anaphylaxis; Biomarkers; Histamine; Humans; Platelet Activating Factor; Tryptases | 2018 |
Phenotypes, endotypes and biomarkers in anaphylaxis: current insights.
Topics: Anaphylaxis; Basophils; Biomarkers; Bradykinin; Carboxypeptidases A; Chymases; Complement Activation; Cytokines; Histamine; Humans; Immunoglobulin E; Immunoglobulin G; Interleukin-6; Mast Cells; Phenotype; Platelet Activating Factor; Precision Medicine; Tryptases | 2018 |
Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives.
Topics: Anaphylaxis; Autopsy; Biomarkers; Costs and Cost Analysis; Forensic Medicine; Humans; Mast Cells; Metabolomics; Platelet Activating Factor; Specimen Handling; Tryptases | 2019 |
Anaphylaxis and cardiovascular diseases: a dangerous liaison.
Topics: Anaphylaxis; Cardiovascular Diseases; Histamine; Humans; Inflammation; Mastocytosis; Platelet Activating Factor; Prostaglandins | 2014 |
Biomarkers of anaphylaxis, beyond tryptase.
Topics: Anaphylaxis; Biomarkers; Cell Degranulation; Cytokines; Humans; Mast Cells; Platelet Activating Factor; Risk Factors; Tryptases | 2015 |
Platelet activating factor in allergies.
Topics: Anaphylaxis; Asthma; Eosinophils; Humans; Mast Cells; Platelet Activating Factor; Urticaria | 2015 |
Anaphylaxis in children.
Topics: Anaphylaxis; Bronchodilator Agents; Child; Epinephrine; Evidence-Based Medicine; Glucocorticoids; Humans; National Institute of Allergy and Infectious Diseases (U.S.); Peanut Hypersensitivity; Platelet Activating Factor; Practice Guidelines as Topic; Signal Transduction; United States | 2016 |
The platelet-activating factor pathway in food allergy and anaphylaxis.
Topics: Anaphylaxis; Animals; Food Hypersensitivity; Homeostasis; Humans; Platelet Activating Factor; Signal Transduction | 2016 |
New insights into the roles for basophils in acute and chronic allergy.
Topics: Acute Disease; Anaphylaxis; Basophils; Chronic Disease; Histamine Release; Humans; Hypersensitivity; Immunoglobulin E; Immunoglobulin G; Macrophages; Platelet Activating Factor | 2009 |
Anaphylaxis: an update on its understanding and management.
Topics: Anaphylaxis; Animals; Food Hypersensitivity; Humans; Immunotherapy; Lysophospholipids; Patents as Topic; Platelet Activating Factor; Signal Transduction; Sphingosine | 2010 |
Role for basophils in systemic anaphylaxis.
Topics: Anaphylaxis; Animals; Basophils; Capillary Permeability; Disease Models, Animal; Humans; Immunoglobulin G; Platelet Activating Factor | 2010 |
In vitro diagnosis of anaphylaxis.
Topics: Anaphylaxis; Animals; Basophil Degranulation Test; Histamine; Humans; Immunoglobulin E; Leukotrienes; Mast Cells; Platelet Activating Factor; Tryptases | 2010 |
Pathophysiology of anaphylaxis.
Topics: Anaphylaxis; Animals; Basophils; Cardiovascular System; Cytokines; Histamine Release; Humans; Immunoglobulin E; Immunoglobulin G; Inflammation Mediators; Macrophage Activation; Mast Cells; Mice; Nitric Oxide; Platelet Activating Factor; Receptors, Immunologic; Serotonin; Tryptases; Water-Electrolyte Balance | 2011 |
Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.
Topics: Allergens; Anaphylaxis; Antibodies; Basophils; Blood Proteins; Histamine; Humans; Immunity, Cellular; Immunization, Passive; Immunoglobulin A; Immunoglobulin E; Immunologic Tests; Mast Cells; Plasma; Platelet Activating Factor; Receptors, IgG; Transfusion Reaction | 2013 |
[Value of in-vitro diagnostic tools after anaphylaxis].
Topics: Anaphylaxis; Antibody Specificity; Basophil Degranulation Test; Biomarkers; Epitopes; Germany; Guideline Adherence; Histamine; Humans; Immunoglobulin E; In Vitro Techniques; Intradermal Tests; Platelet Activating Factor; Predictive Value of Tests; Reagent Kits, Diagnostic; Secondary Prevention; Tryptases | 2013 |
Basophils are back!
Topics: Anaphylaxis; Animals; Basophils; Humans; Immunoglobulin G; Mice; Platelet Activating Factor | 2008 |
Lipid mediators of inflammation and allergy.
Topics: Anaphylatoxins; Anaphylaxis; Animals; Antibodies; Arachidonic Acids; Autacoids; Blood Platelets; Bradykinin; Complement System Proteins; Dogs; Haplorhini; Histamine; Humans; Hypersensitivity; Inflammation; Lipids; Neutrophils; Platelet Activating Factor; Rabbits; Serotonin | 1982 |
Mediators of anaphylaxis and inflammation.
Topics: Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Autacoids; Chemical Phenomena; Chemistry; Chemotactic Factors; Chemotactic Factors, Eosinophil; Histamine; Humans; Hydrolases; Inflammation; Leukocytes; Leukotriene B4; Mast Cells; Platelet Activating Factor; Prostaglandins; Serotonin; SRS-A; Structure-Activity Relationship; Thromboxanes; Vasoactive Intestinal Peptide | 1982 |
Biology and biochemistry of platelet-activating factor.
Topics: Anaphylaxis; Animals; Blood Platelets; Calcium; Dogs; Guinea Pigs; Humans; Inflammation; Leukocytes; Lipid Metabolism; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats | 1983 |
Platelet-activating factor.
Topics: Anaphylaxis; Animals; Blood Platelets; Cardiovascular System; Desensitization, Immunologic; Guinea Pigs; Humans; Immunization; Immunoglobulin E; Lung; Papio; Platelet Activating Factor; Platelet Aggregation; Rabbits; Time Factors; Vasoconstriction | 1983 |
[Platelet-activating factor (PAF) receptor-related pathophysiology].
Topics: Anaphylaxis; Animals; Humans; Mice; Mice, Knockout; Mice, Transgenic; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reproduction; Shock, Septic | 1999 |
Role of platelet-activating factor in cardiovascular pathophysiology.
Topics: Anaphylaxis; Animals; Cardiovascular Diseases; Cells, Cultured; Endothelium, Vascular; Heart; Hemodynamics; Humans; In Vitro Techniques; Microcirculation; Myocardium; Neovascularization, Pathologic; Neovascularization, Physiologic; Organ Specificity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Reperfusion Injury; Signal Transduction | 2000 |
Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants.
Topics: Anaphylaxis; Animals; Blood Platelets; Cardiovascular Agents; Furans; Hemodynamics; In Vitro Techniques; Lignans; Plant Extracts; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Stereoisomerism | 2001 |
The effects of hetrazepine PAF antagonists in preclinical models of asthma.
Topics: Anaphylaxis; Animals; Antigens; Asthma; Azepines; Blood Platelets; Bronchi; Bronchoconstriction; Capillary Permeability; Cell Movement; Eosinophils; Lung; Platelet Activating Factor; Respiratory Hypersensitivity; Triazoles | 1991 |
Pharmacological studies of pulmonary anaphylaxis in vitro: a review.
Topics: Anaphylaxis; Animals; Antigens; Cell Separation; Chemotactic Factors, Eosinophil; Disease Models, Animal; Dopamine; Histamine Release; Humans; In Vitro Techniques; Kinins; Lung; Lung Diseases; Mast Cells; Muscle Contraction; Muscle, Smooth, Vascular; Perfusion; Platelet Activating Factor; Prostaglandins; Receptors, Adrenergic, beta; Serotonin; SRS-A; Thromboxanes; Trachea | 1985 |
Acute and long-term pulmonary effects of platelet-activating factor.
Topics: Anaphylaxis; Animals; Bronchial Spasm; Humans; Leukotrienes; Lung; Platelet Activating Factor; Prostaglandins; Substance P | 1989 |
[Platelet activating factor (PAF) and its inhibitors].
Topics: Anaphylaxis; Cardiovascular Diseases; Digestive System Diseases; Histamine H1 Antagonists; Histamine Release; Humans; Lignans; Lignin; Platelet Activating Factor; Terpenes | 1988 |
PAF-acether and experimental anaphylaxis as a model for asthma.
Topics: Anaphylaxis; Animals; Asthma; Eosinophils; Guinea Pigs; Leukotrienes; Lung; Macrophages; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1989 |
The role of basophils and mast cells in the pathogenesis of pulmonary diseases.
Topics: Anaphylaxis; Arachidonic Acid; Arachidonic Acids; Asthma; Basophils; Blood Platelets; Bronchial Provocation Tests; Calmodulin; Cyclic AMP; Deuterium; Deuterium Oxide; Histamine Release; Humans; Lung Diseases; Mast Cells; Peptide Hydrolases; Phospholipids; Platelet Activating Factor; Platelet Factor 4; Prostaglandin D2; Prostaglandins D; Receptors, IgE; Receptors, Immunologic; Serotonin; Water | 1985 |
[The barley cell or mastocyte: cellular and molecular biology].
Topics: Anaphylaxis; Animals; Blood Coagulation Factors; Cell Differentiation; Cytoplasmic Granules; Exocytosis; Histamine Release; Humans; Hypersensitivity; Immunity, Cellular; Inflammation; Mast Cells; Mice; Platelet Activating Factor; Rats; Receptors, IgE; Receptors, Immunologic; Serotonin; SRS-A; Stem Cells | 1985 |
[Platelet-activating factor and disease].
Topics: Anaphylaxis; Animals; Asthma; Capillary Permeability; Humans; Muscle Contraction; Platelet Activating Factor; Platelet Aggregation; Shock, Septic | 1989 |
Lipid mediators of anaphylaxis and increased airways reactivity.
Topics: Anaphylaxis; Arachidonic Acids; Asthma; Bronchitis; Histamine; Humans; Leukotriene B4; Lipid Metabolism; Platelet Activating Factor; SRS-A | 1987 |
PAF-acether today--relevance for acute experimental anaphylaxis.
Topics: Anaphylaxis; Animals; Blood Platelets; Chemical Phenomena; Chemistry; Humans; Hypersensitivity, Immediate; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1987 |
Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Topics: Anaphylaxis; Animals; Bronchial Spasm; Diterpenes; Ginkgolides; Graft Rejection; Hemodynamics; Humans; Immune System Diseases; In Vitro Techniques; Kidney Diseases; Lactones; Leukocytes; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Shock; Thrombosis | 1986 |
Thyrotropin-releasing hormone (TRH) and circulatory shock.
Topics: Anaphylaxis; Animals; Brain; Cardiovascular System; Cats; Endorphins; Guinea Pigs; Hypotension; Lipoxygenase Inhibitors; Platelet Activating Factor; Rats; Shock; Shock, Hemorrhagic; Shock, Septic; SRS-A; Thyrotropin-Releasing Hormone | 1986 |
Anti-anaphylactic properties of BN 52021: a potent platelet activating factor antagonist.
Topics: Anaphylaxis; Animals; Antigens; Diterpenes; Ginkgolides; In Vitro Techniques; Lactones; Lung; Plant Extracts; Platelet Activating Factor | 1987 |
The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021.
Topics: Anaphylaxis; Animals; Diterpenes; Ginkgolides; Humans; Lactones; Lung; Plant Extracts; Platelet Activating Factor; T-Lymphocytes | 1987 |
Eicosanoids and the coronary circulation.
Topics: Anaphylaxis; Animals; Coronary Circulation; Coronary Disease; Epoprostenol; Fatty Acids, Unsaturated; Humans; Myocardial Infarction; Platelet Activating Factor; Thromboxanes | 1986 |
Anaesthesia and allergic drug reactions.
Topics: Anaphylaxis; Anesthesia; Anesthetics; Drug Hypersensitivity; Histamine; Humans; Platelet Activating Factor; Prostaglandins; Skin Tests | 1986 |
171 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Anaphylaxis
Article | Year |
---|---|
Platelet-activating factor acetylhydrolase is a biomarker of severe anaphylaxis in children.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Anaphylaxis; Biomarkers; Child; Humans; Platelet Activating Factor | 2022 |
Biotinylated peptides substituted with D-amino acids with high stability as anti-anaphylactic agents targeting platelet-activating factor.
Topics: Amino Acids; Anaphylaxis; Animals; Edema; Hypothermia; Mice; Peptides; Platelet Activating Factor; Rats | 2022 |
Clinacanthus nutans aqueous leaves extract exerts anti-allergic activity in preclinical anaphylactic models via alternative IgG pathway.
Topics: Anaphylaxis; Animals; Anti-Allergic Agents; Histamine; Immunoglobulin E; Immunoglobulin G; Interleukin-4; Interleukin-6; Mast Cells; Mice; Mice, Inbred C57BL; Ovalbumin; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2023 |
Tumor-associated neutrophils and macrophages exacerbate antidrug IgG-mediated anaphylactic reaction against an immune checkpoint inhibitor.
Topics: Anaphylaxis; Animals; Chromatography, Liquid; Humans; Immune Checkpoint Inhibitors; Immunoglobulin G; Macrophages; Mice; Neoplasms; Neutrophils; Platelet Activating Factor; Tandem Mass Spectrometry | 2022 |
Interaction of mediators and effector cells in cashew nut-induced anaphylaxis.
Topics: Anacardium; Anaphylaxis; Child; Eosinophils; Humans; Lymphocytes; Nuts; Platelet Activating Factor; Tryptases | 2023 |
Mechanisms for hypothermia during anaphylactic hypotension in awake rats.
Topics: Anaphylaxis; Animals; Histamine; Hypotension; Hypothermia; Platelet Activating Factor; Rats; Wakefulness | 2023 |
The TNF-like weak inducer of the apoptosis/fibroblast growth factor-inducible molecule 14 axis mediates histamine and platelet-activating factor-induced subcutaneous vascular leakage and anaphylactic shock.
Topics: Anaphylaxis; Animals; Capillary Permeability; Cytokine TWEAK; Endothelial Cells; Histamine; Mice; Mice, Knockout; Platelet Activating Factor; TWEAK Receptor | 2020 |
The TWEAK/Fn14 axis in anaphylactic shock.
Topics: Anaphylaxis; Apoptosis; Fibroblast Growth Factors; Histamine; Humans; Platelet Activating Factor | 2020 |
Clinical significance of plasma PAF acetylhydrolase activity measurements as a biomarker of anaphylaxis: Cross-sectional study.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Anaphylaxis; Animals; Bees; Biomarkers; Body Mass Index; Case-Control Studies; Female; Humans; Immunoglobulin E; Insect Bites and Stings; Male; Middle Aged; Platelet Activating Factor; ROC Curve; Severity of Illness Index; Wasps | 2021 |
Influence of glucocorticoids on time-of-day-dependent variations in IgE-, histamine-, and platelet-activating factor-mediated systemic anaphylaxis in different mouse strains.
Topics: Anaphylaxis; Animals; Circadian Rhythm; Disease Models, Animal; Glucocorticoids; Histamine; Immunoglobulin E; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Platelet Activating Factor; Species Specificity | 2018 |
An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis.
Topics: Adult; Aged; Anaphylaxis; Antibody Specificity; Biomarkers; Down-Regulation; Female; Humans; Immunoglobulin E; Immunoglobulin G; Male; Middle Aged; Myeloid Cells; Neuromuscular Blocking Agents; Neutrophil Activation; Platelet Activating Factor; Receptors, IgG; Severity of Illness Index | 2019 |
Serum tryptase determination in patients with acute allergic reactions.
Topics: Anaphylaxis; Female; Histamine; Humans; Male; Platelet Activating Factor; Tryptases | 2013 |
Reply: To PMID 23040367.
Topics: Anaphylaxis; Female; Histamine; Humans; Male; Platelet Activating Factor; Tryptases | 2013 |
Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Topics: Adherens Junctions; Anaphylaxis; Animals; Aorta; beta Catenin; Capillary Permeability; Disease Models, Animal; Endothelial Cells; Enzyme Activation; Gene Deletion; Lung; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Platelet Activating Factor; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; Signal Transduction | 2013 |
Basophil activation through ASGM1 stimulation triggers PAF release and anaphylaxis-like shock in mice.
Topics: Anaphylaxis; Animals; Antibodies; Antigens; Basophils; Capillary Permeability; Cells, Cultured; Female; Immunoglobulin E; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Receptors, Cell Surface | 2014 |
Mouse anaphylactic shock is caused by reduced cardiac output, but not by systemic vasodilatation or pulmonary vasoconstriction, via PAF and histamine.
Topics: Anaphylaxis; Animals; Arterial Pressure; Cardiac Output; Diphenhydramine; Hemodynamics; Histamine; Hypotension; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, G-Protein-Coupled; Vascular Resistance; Vasoconstriction; Vasodilation | 2014 |
Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anaphylaxis; Asthma; Blood Platelets; Eosinophils; Gene Expression Regulation; Humans; Mast Cells; Neutrophils; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Sepsis; Signal Transduction | 2015 |
The responses of pulmonary and systemic circulation and airway to anaphylactic mediators in anesthetized BALB/c mice.
Topics: Anaphylaxis; Animals; Arterial Pressure; Dose-Response Relationship, Drug; Histamine; Leukotriene C4; Male; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Activating Factor; Prostaglandin D2; Serotonin; Vascular Resistance; Vasoconstriction; Vasodilation | 2016 |
Glutamine Prevents Late-Phase Anaphylaxis via MAPK Phosphatase 1-Dependent Cytosolic Phospholipase A2 Deactivation.
Topics: Anaphylaxis; Animals; Disease Models, Animal; Dual Specificity Phosphatase 1; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Glutamine; Leukotriene B4; Mice; Mice, Knockout; p38 Mitogen-Activated Protein Kinases; Phospholipases A2, Cytosolic; Phosphorylation; Platelet Activating Factor; RNA, Small Interfering | 2016 |
PAF, rather than histamine, participates in mouse anaphylactic hypotension.
Topics: Anaphylaxis; Animals; Blood Pressure; Diphenhydramine; Histamine; Histamine H1 Antagonists; Hypotension; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Receptors, G-Protein-Coupled; Receptors, Histamine H1 | 2008 |
Toxoplasma gondii-derived heat shock protein 70 induces lethal anaphylactic reaction through activation of cytosolic phospholipase A2 and platelet-activating factor via Toll-like receptor 4/myeloid differentiation factor 88.
Topics: Adaptor Proteins, Vesicular Transport; Anaphylaxis; Animals; CD11b Antigen; HSP70 Heat-Shock Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Phospholipases A2; Platelet Activating Factor; Protozoan Proteins; T-Lymphocyte Subsets; Toll-Like Receptor 2; Toll-Like Receptor 4; Toxoplasma | 2008 |
Peanuts can contribute to anaphylactic shock by activating complement.
Topics: Adrenergic beta-Antagonists; Allergens; Anaphylaxis; Animals; Arachis; Basophils; Cell Degranulation; Chymases; Complement Activation; Complement C3a; Histamine; Humans; Immunoglobulin E; Interleukin-4; Macrophages; Mast Cells; Mice; Mice, Inbred BALB C; Peanut Hypersensitivity; Platelet Activating Factor; Propranolol; Receptors, IgG; Toll-Like Receptors | 2009 |
Anaphylaxis to a self-peptide in the absence of mast cells or histamine.
Topics: Adjuvants, Immunologic; Anaphylaxis; Animals; Bacterial Toxins; Bordetella pertussis; Encephalomyelitis, Autoimmune, Experimental; Glycoproteins; Histamine; Histidine Decarboxylase; Immunization; Immunoglobulin E; Interleukin-4; Mast Cells; Mice; Mice, Knockout; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; Platelet Activating Factor; Pyridinium Compounds; Th1 Cells; Th2 Cells | 2009 |
Activation of human mast cells through the platelet-activating factor receptor.
Topics: Anaphylaxis; Cells, Cultured; Histamine Release; Humans; Lung; Mast Cells; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Skin | 2010 |
Mouse and human neutrophils induce anaphylaxis.
Topics: Anaphylaxis; Animals; Basophils; Humans; Immunoglobulin G; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Mice, Transgenic; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Receptors, IgG; Species Specificity | 2011 |
Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock.
Topics: Anaphylaxis; Animals; Benzimidazoles; Blotting, Western; Casein Kinase II; Female; Lung; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet Activating Factor; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction | 2011 |
Stimulation of Ly-6G on neutrophils in LPS-primed mice induces platelet-activating factor (PAF)-mediated anaphylaxis-like shock.
Topics: Anaphylaxis; Animals; Antibodies, Monoclonal; Antigens, Ly; Leukocyte Reduction Procedures; Lipopolysaccharides; Liver; Lung; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Neutrophils; Platelet Activating Factor; Time Factors | 2012 |
Contribution of classic and alternative effector pathways in peanut-induced anaphylactic responses.
Topics: Anaphylaxis; Animals; Antibody Formation; Antibody Specificity; Blood Platelets; Cell Degranulation; Ear; Immune System Phenomena; Immunity, Humoral; Immunization; Leukocytes; Mast Cells; Mice; Mice, Inbred Strains; Mucous Membrane; Peanut Hypersensitivity; Plant Extracts; Platelet Activating Factor; T-Lymphocytes | 2011 |
Effect of epinephrine on platelet-activating factor-stimulated human vascular smooth muscle cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Anaphylaxis; Aorta; Cells, Cultured; Dinoprostone; Epinephrine; Humans; Myocytes, Smooth Muscle; Platelet Activating Factor | 2012 |
[Changes of prostaglandin D2,carboxypeptidase A3 and platelet activating factor in guinea pig in anaphylactic shock].
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anaphylaxis; Animals; Brain; Carboxypeptidases; Case-Control Studies; Disease Models, Animal; Egg Proteins; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Leukotriene E4; Male; Mice; Platelet Activating Factor; Prostaglandin D2; Time Factors | 2012 |
Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis.
Topics: Adolescent; Adult; Aged; Anaphylaxis; Cross-Sectional Studies; Female; Histamine; Humans; Male; Middle Aged; Platelet Activating Factor; Tryptases; Young Adult | 2013 |
IL-4 exacerbates anaphylaxis.
Topics: Adjuvants, Immunologic; Anaphylaxis; Animals; Capillary Leak Syndrome; Dose-Response Relationship, Immunologic; Drug Therapy, Combination; Female; Injections, Intravenous; Interleukin-12; Interleukin-13; Interleukin-18; Interleukin-4; Leukotriene C4; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Mice, Nude; Mice, Transgenic; Platelet Activating Factor; Serotonin; Signal Transduction; STAT6 Transcription Factor; Trans-Activators | 2003 |
Platelet-activating factor-mediated NF-kappaB dependency of a late anaphylactic reaction.
Topics: Anaphylaxis; Animals; Hematocrit; Interleukin-1; Male; Mast Cells; Mice; Mice, Inbred C57BL; NF-kappa B; Phospholipases A; Platelet Activating Factor; Tumor Necrosis Factor-alpha | 2003 |
Mast cells are required for experimental oral allergen-induced diarrhea.
Topics: Allergens; Anaphylaxis; Animals; Chymases; Diarrhea; Eosinophils; Immunoglobulin E; Intestinal Mucosa; Mast Cells; Mastocytosis; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Permeability; Platelet Activating Factor; Serine Endopeptidases; Serotonin; Th2 Cells | 2003 |
Helminth infection protects mice from anaphylaxis via IL-10-producing B cells.
Topics: Adoptive Transfer; Anaphylaxis; Animals; Antigens, Differentiation; B-Lymphocyte Subsets; Cells, Cultured; Cytokines; Female; Genetic Predisposition to Disease; Host-Parasite Interactions; Immunity, Innate; Immunization, Passive; Interleukin-10; Interleukin-4; Macrophage-1 Antigen; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Penicillin V; Platelet Activating Factor; Receptors, Interleukin-2; Schistosomiasis mansoni; T-Lymphocyte Subsets; Th2 Cells; Up-Regulation | 2004 |
Antianaphylactic and antipruritic effects of the flowers of Impatiens textori MIQ.
Topics: Anaphylaxis; Animals; Behavior, Animal; Blood Pressure; Flowers; Hypnotics and Sedatives; Immunoglobulin E; Impatiens; Male; Mice; Motor Activity; Muramidase; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Pruritus; Regional Blood Flow; Serotonin | 2005 |
Mechanism for acute oral desensitization to antibiotics.
Topics: Administration, Oral; Anaphylaxis; Animals; Anti-Bacterial Agents; Desensitization, Immunologic; Disease Models, Animal; Drug Hypersensitivity; Female; Histamine; Immunoglobulin E; Mast Cells; Mice; Penicillin V; Platelet Activating Factor | 2006 |
Anaphylactic shock depends on PI3K and eNOS-derived NO.
Topics: Anaphylaxis; Animals; Blood Pressure; Cardiovascular Diseases; Enzyme Inhibitors; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type III; Oxadiazoles; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Quinoxalines; Serum Albumin, Bovine; Transcription, Genetic | 2006 |
Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70.
Topics: Anaphylaxis; Animals; HSP70 Heat-Shock Proteins; Interferon-gamma; Mice; Mice, Inbred BALB C; Mice, Knockout; Platelet Activating Factor; Protozoan Proteins; Pyridinium Compounds; Toxoplasma; Toxoplasmosis, Animal | 2006 |
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Aged; Anaphylaxis; Asthma; Biomarkers; Case-Control Studies; Child; Child, Preschool; Drug Hypersensitivity; Epinephrine; Female; Humans; Injections, Intramuscular; Insect Bites and Stings; Male; Peanut Hypersensitivity; Platelet Activating Factor; Prospective Studies; Retrospective Studies; Risk Factors; Severity of Illness Index | 2008 |
Factoring PAF in anaphylaxis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anaphylaxis; Biomarkers; Drug Hypersensitivity; Food Hypersensitivity; Humans; Insect Bites and Stings; Platelet Activating Factor; Severity of Illness Index | 2008 |
Small bowel injury associated to allergy is triggered by platelet-activating factor, mast cells, neutrophils and protected by nitric oxide.
Topics: Anaphylaxis; Animals; Gastrointestinal Hemorrhage; Male; Mast Cells; Neutrophils; Nitric Oxide; Platelet Activating Factor; Rats; Rats, Wistar; Secretin | 2008 |
Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis.
Topics: Allergens; Anaphylaxis; Animals; Basophils; Immunoglobulin E; Immunoglobulin G; Macrophages; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Transgenic; Ovalbumin; Platelet Activating Factor; Receptors, IgG; Signal Transduction | 2008 |
Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anaphylaxis; Histamine; Humans; Platelet Activating Factor; Tryptases | 2008 |
Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anaphylaxis; Humans; Platelet Activating Factor | 2008 |
Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anaphylaxis; Case-Control Studies; Humans; Platelet Activating Factor | 2008 |
High dose of lipopolysaccharide pre-treatment prevents OVA-induced anaphylactic decreases in rectal temperature in the immunized mice.
Topics: Allergens; Anaphylaxis; Animals; Antibody Formation; Body Temperature; Histamine; Immunization; Immunoglobulin E; Immunoglobulin G; Lipopolysaccharides; Male; Mice; Ovalbumin; Platelet Activating Factor; Rectum | 2008 |
Pharmacological modulation of platelet-activating factor (PAF) release from rabbit leucocytes. I. Role of cAMP.
Topics: Anaphylaxis; Animals; Antigens; Basophils; Blood Platelets; Bucladesine; Cyclic AMP; Dose-Response Relationship, Immunologic; Female; Histamine Release; Isoproterenol; Leukocytes; Lysophosphatidylcholines; Male; Platelet Activating Factor; Platelet Aggregation; Rabbits; Theophylline | 1980 |
Bronchial anaphylaxis in actively sensitized Sprague Dawley rats: studies on mediators involved.
Topics: Acetylcholine; Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Bradykinin; Bronchi; Cyclooxygenase Inhibitors; Immunization; Indomethacin; Male; Methysergide; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serotonin; Vagotomy | 1984 |
On the nature of the vasoreactivity depressing factor (VDF) in inflammation and anaphylaxis in the rat and mouse.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Alprostadil; Anaphylaxis; Animals; Anti-Inflammatory Agents; Epoprostenol; Female; Histamine; Indomethacin; Inflammation; Male; Mice; Mice, Inbred Strains; Norepinephrine; Platelet Activating Factor; Prostaglandins E; Pyrazoles; Rats; Rats, Inbred Strains; Serotonin; Vasopressins | 1984 |
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction.
Topics: Anaphylaxis; Animals; Blood Platelets; Bronchi; Guinea Pigs; Histamine; In Vitro Techniques; Lipid Metabolism; Lung; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Rabbits; SRS-A; Thromboxanes | 1983 |
Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.
Topics: Anaphylaxis; Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Vessels; Guinea Pigs; Heart; Heart Ventricles; Male; Myocardial Contraction; Platelet Activating Factor | 1984 |
Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation.
Topics: Acetylcholine; Anaphylaxis; Animals; Complement C5; Complement C5a; Histamine; Immunoglobulin E; In Vitro Techniques; Lung; Muscle Contraction; Platelet Activating Factor; Rabbits | 1983 |
Anaphylactic actions of platelet-activating factor.
Topics: Anaphylatoxins; Anaphylaxis; Animals; Blood Coagulation Factors; Capillary Permeability; Complement C3; Complement C3a; Complement C5; Complement C5a; Guinea Pigs; Ileum; Lung; Lysophosphatidylcholines; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Receptors, Complement | 1981 |
Platelet-tissue interaction: role of platelet-activating factor (PAF-acether).
Topics: Anaphylaxis; Animals; Antigen-Antibody Complex; Blood Platelets; Bronchi; Capillary Permeability; Inflammation; Lysophosphatidylcholines; Macrophages; Mice; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1980 |
Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs.
Topics: Anaphylaxis; Animals; Dose-Response Relationship, Drug; Female; Guinea Pigs; Infusions, Parenteral; Leukocyte Count; Leukopenia; Lysophosphatidylcholines; Male; Papio; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Rabbits; Thrombocytopenia | 1981 |
Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.
Topics: Anaphylaxis; Animals; Antigens; Blood Coagulation Factors; Blood Platelets; Blood Pressure; Female; Goats; Heart Rate; Horseradish Peroxidase; Immune Sera; Immunoglobulin E; Lung Compliance; Lysophosphatidylcholines; Male; Platelet Activating Factor; Rabbits; Respiration | 1981 |
Acetyl glyceryl ether phosphorylcholine: platelet-activating factor.
Topics: Anaphylaxis; Animals; Basophils; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; In Vitro Techniques; Lysophosphatidylcholines; Phosphorylcholine; Platelet Activating Factor; Rabbits | 1981 |
Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit.
Topics: Anaphylaxis; Animals; Blood Pressure; Female; Heart; Heart Rate; Lung; Lung Compliance; Lysophosphatidylcholines; Male; Platelet Activating Factor; Rabbits; Respiration; Vascular Resistance | 1980 |
Capsaicin sensitive nerves in the jejunum of Nippostrongylus brasiliensis-sensitized rats participate in a cardiovascular depressor reflex.
Topics: Anaphylaxis; Animals; Animals, Newborn; Blood Pressure; Capsaicin; Diterpenes; Ginkgolides; Guanethidine; Hemodynamics; Indomethacin; Jejunum; Lactones; Male; Neurons, Afferent; Nippostrongylus; Platelet Activating Factor; Pyrilamine; Rats; Rats, Sprague-Dawley; Reflex; Ruthenium Red; Strongylida Infections | 1993 |
Relevance of mediators to cardiac parameters of isolated anaphylactic guinea-pig heart.
Topics: 6-Ketoprostaglandin F1 alpha; Anaphylaxis; Animals; Catecholamines; Eicosanoids; Epinephrine; Guinea Pigs; Heart; Histamine Release; Kinetics; Leukotrienes; Male; Norepinephrine; Ovalbumin; Platelet Activating Factor; Thromboxane B2 | 1995 |
GABA-mediated inhibition of the anaphylactic response in the guinea-pig trachea.
Topics: Anaphylaxis; Animals; beta-Alanine; Bronchial Hyperreactivity; Capsaicin; Drug Interactions; Epithelial Cells; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Guinea Pigs; Histamine Release; Macrophage Activation; Macrophages, Alveolar; Male; Mast Cells; Muscle Contraction; Muscle, Smooth; N-Formylmethionine Leucyl-Phenylalanine; Nipecotic Acids; Ovalbumin; Platelet Activating Factor; Proline; Receptors, GABA; Tetrodotoxin; Trachea | 1995 |
Compound PCA-4248 interferes with bronchopulmonary anaphylaxis and with in vitro hyperresponsiveness to platelet-activating factor.
Topics: Anaphylaxis; Animals; Blood Cell Count; Bronchial Hyperreactivity; Bronchoconstriction; Dihydropyridines; Female; Guinea Pigs; Histamine Release; Immunization; In Vitro Techniques; Injections, Intravenous; Lung; Male; Platelet Activating Factor; Radioimmunoassay; Thromboxane B2 | 1993 |
Preclinical efficacy of emedastine, a potent, selective histamine H1 antagonist for topical ocular use.
Topics: Administration, Topical; Anaphylaxis; Animals; Benzimidazoles; Capillary Permeability; Conjunctiva; Conjunctivitis, Allergic; Drug Evaluation, Preclinical; Guinea Pigs; Histamine; Histamine H1 Antagonists; Male; Ophthalmic Solutions; Ovalbumin; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Serotonin | 1994 |
Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor.
Topics: Anaphylaxis; Animals; Azepines; Disseminated Intravascular Coagulation; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet Activating Factor; Triazoles | 1995 |
Altered inflammatory responses in leukotriene-deficient mice.
Topics: Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Chemotaxis, Leukocyte; Dinoprostone; Edema; Inflammation; Leukotriene C4; Leukotrienes; Macrophages; Mice; Mice, Knockout; Neutrophils; Platelet Activating Factor; Thromboxane B2 | 1994 |
[(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
Topics: Anaphylaxis; Animals; Benzocycloheptenes; Blood Pressure; Guinea Pigs; Histamine; Histamine H1 Antagonists; Ileum; In Vitro Techniques; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Structure; Muscle Contraction; Muscle, Smooth; Piperidines; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1994 |
Study of the effector mechanism involved in the production of haemorrhagic necrosis of the small intestine in rat passive anaphylaxis.
Topics: Anaphylaxis; Animals; Blood Pressure; Capillary Permeability; Complement System Proteins; Dinitrophenols; Gastrointestinal Hemorrhage; Intestine, Small; Male; Necrosis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine; Tumor Necrosis Factor-alpha | 1994 |
Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma.
Topics: Anaphylaxis; Animals; Azepines; Guinea Pigs; Histamine; In Vitro Techniques; Indoles; Indomethacin; Leukotriene Antagonists; Leukotrienes; Lung; Male; Muscle Contraction; Ovalbumin; Platelet Activating Factor; Quinolines; Triazoles | 1994 |
Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene.
Topics: Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Base Sequence; Female; Inflammation; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Molecular Sequence Data; Platelet Activating Factor; Shock; Shock, Septic | 1994 |
In vivo responses of mouse blood cells to platelet-activating factor (PAF): role of the mediators of anaphylaxis.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Cells; Chlorpromazine; Erythrocyte Count; Histamine Antagonists; Leukocyte Count; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Count; Promethazine; Serotonin Antagonists; Sulfinpyrazone | 1993 |
Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
Topics: Anaphylaxis; Animals; Blood Platelets; Blood Pressure; Endotoxins; Guinea Pigs; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Stereoisomerism; Thiazoles; Thiazolidines | 1994 |
Rat gastric motor response to food protein-induced anaphylaxis.
Topics: Albumins; Anaphylaxis; Animals; Dietary Proteins; Gastrointestinal Motility; Histamine Antagonists; Indomethacin; Lipoxygenase Inhibitors; Mast Cells; Muscle Contraction; Ovum; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stomach; Tetrodotoxin | 1994 |
Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis.
Topics: Acetylcholine; Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Asthma; Bronchoconstriction; Bronchodilator Agents; Calcimycin; Chromones; Guinea Pigs; Male; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pyrazoles; Pyridines; SRS-A | 1993 |
Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl)cyanomethyl)piperazines as PAF antagonists.
Topics: Anaphylaxis; Animals; Blood Pressure; Endotoxins; Escherichia coli; Male; Mice; Molecular Structure; Piperazines; Platelet Activating Factor; Platelet Aggregation; Pyridines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 1993 |
The effects of combined histamine and platelet-activating factor antagonism on systemic anaphylaxis induced by immunoglobulin E in the rabbit.
Topics: Airway Resistance; Anaphylaxis; Animals; Azepines; Basophil Degranulation Test; Blood Pressure; Chlorpheniramine; Cimetidine; Histamine; Immunoglobulin E; Leukocyte Count; Lung Compliance; Platelet Activating Factor; Rabbits; Serotonin; Tidal Volume; Triazoles | 1993 |
Involvement of platelet-activating factor in death following anaphylactic shock in boosted and in unboosted mice.
Topics: Anaphylaxis; Animals; Azepines; Immunization, Secondary; Immunoglobulin E; Immunoglobulin G; Male; Mice; Ovalbumin; Platelet Activating Factor; Triazoles; Vaccination | 1993 |
Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.
Topics: Anaphylaxis; Animals; Bronchial Spasm; Bronchoconstriction; Enzyme Inhibitors; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Indoles; Leukotriene D4; Lung; Male; Methacrylates; Platelet Activating Factor; Rabbits; Thromboxane A2; Thromboxane-A Synthase; Trachea | 1996 |
Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses.
Topics: 5-Lipoxygenase-Activating Proteins; Anaphylaxis; Animals; Arachidonic Acid; Carrier Proteins; DNA, Complementary; Edema; Eicosanoids; Hypersensitivity, Delayed; Immunoglobulin E; Inflammation; Macrophages, Peritoneal; Membrane Proteins; Mice; Mice, Knockout; Peritonitis; Peroxidase; Platelet Activating Factor; RNA, Messenger; Transcription, Genetic; Zymosan | 1997 |
Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Antigens; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Bronchodilator Agents; Dogs; Eosinophils; Guinea Pigs; Histamine; Hypersensitivity; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Naphthyridines; Phosphodiesterase Inhibitors; Platelet Activating Factor; Rabbits; Tumor Necrosis Factor-alpha | 1997 |
Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin.
Topics: Anaphylaxis; Animals; Chemokine CCL11; Chemokines, CC; Chemotactic Factors, Eosinophil; Chemotaxis, Leukocyte; Complement C5a; Cytokines; Eosinophils; Female; Hypersensitivity; Hypersensitivity, Delayed; Leukotriene B4; Mice; Mice, Inbred CBA; Platelet Activating Factor; Receptors, CCR3; Receptors, Chemokine; Skin | 1997 |
Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Ascaris suum; Blood Pressure; Capillary Permeability; Dogs; Eicosanoids; Female; Histamine; Histamine H1 Antagonists; In Vitro Techniques; Leukocyte Count; Lung; Male; Platelet Activating Factor; Pulmonary Circulation; Thromboxanes; Vasoconstriction | 1997 |
Role of cytosolic phospholipase A2 in allergic response and parturition.
Topics: Anaphylaxis; Animals; Bronchial Hyperreactivity; Chimera; Cloning, Molecular; Cytosol; Eicosanoids; Female; Gene Targeting; Hypersensitivity; Labor, Obstetric; Macrophages, Peritoneal; Male; Methacholine Chloride; Mice; Mice, Inbred C57BL; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pregnancy | 1997 |
Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice.
Topics: Anaphylaxis; Animals; Antibodies, Monoclonal; Azepines; Female; Haptens; Histamine; Immunoglobulin E; Interleukin-4; Mast Cells; Mice; Mice, Mutant Strains; Penicillin V; Platelet Activating Factor; Triazoles | 1998 |
Suppressive effects of antihistaminic and/or anti-PAF agents on passive anaphylactic shock in mice sensitized with allogeneic monoclonal IgE and IgG1 antibodies and hyperimmune serum.
Topics: Anaphylaxis; Animals; Antibodies, Monoclonal; Cattle; Cyproheptadine; Female; Histamine H1 Antagonists; Immunoglobulin E; Immunoglobulin G; Immunosuppressive Agents; Isoantibodies; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Nude; Piperazines; Platelet Activating Factor; Propranolol; Pyridinium Compounds; Serum Albumin, Bovine; Triprolidine | 1998 |
PAF antagonistic activity of 2-hydroxy-3-methoxybenzoic acid glucose ester from Gentiana scabra.
Topics: Anaphylaxis; Animals; Benzoates; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Glucosides; Mice; Mice, Inbred ICR; Plants, Medicinal; Platelet Activating Factor; Rauwolfia | 1998 |
Screening method for PAF antagonist substances: on the phenolic compounds from Impatients balsamina L.
Topics: Anaphylaxis; Animals; Blood Pressure; Drug Evaluation, Preclinical; Hypotension; Male; Mice; Mice, Inbred Strains; Phenols; Plant Extracts; Platelet Activating Factor | 1999 |
Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice.
Topics: Acute Disease; Anaphylaxis; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Cell Movement; Crosses, Genetic; Cysteine; Dermatitis, Contact; Ear; Epoxide Hydrolases; Fluorescein-5-isothiocyanate; Immunoglobulin E; Inflammation Mediators; Leukotriene B4; Leukotrienes; Lipopolysaccharides; Mice; Mice, Knockout; Neutrophils; Peritonitis; Platelet Activating Factor | 1999 |
Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Anaphylaxis; Animals; Death, Sudden; Humans; Lung; Male; Mice; Mice, Inbred ICR; Peroxidase; Phospholipases A; Platelet Activating Factor; Recombinant Proteins | 2000 |
Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis.
Topics: Anaphylaxis; Animals; Arachidonic Acid; Ear, External; Female; Gene Targeting; Inflammation Mediators; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophils; Peritoneum; Platelet Activating Factor; Receptors, Leukotriene B4; Zymosan | 2000 |
Induction of active systemic anaphylaxis by oral sensitization with ovalbumin in mast-cell-deficient mice.
Topics: Administration, Oral; Anaphylaxis; Animals; Body Weight; Disease Models, Animal; Female; Fever; Food Hypersensitivity; Histamine; Injections, Intraperitoneal; Interferon-gamma; Interleukin-4; Mast Cells; Mice; Mice, Mutant Strains; Organ Size; Ovalbumin; Platelet Activating Factor; Th2 Cells | 2000 |
Anti-CD44 monoclonal antibody (IM7) induces murine systemic shock mediated by platelet activating factor.
Topics: Anaphylaxis; Animals; Anti-Allergic Agents; Antibodies, Monoclonal; Azepines; Capillary Permeability; Cyproheptadine; Diphenhydramine; Erythrocytes; Hyaluronan Receptors; Hypotension; Immunoglobulin Fab Fragments; Immunoglobulin G; Injections, Intravenous; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Platelet Activating Factor; Triazoles | 2002 |
Pathways of anaphylaxis in the mouse.
Topics: Anaphylaxis; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antigens; Blood Platelets; Complement System Proteins; Female; Immunoglobulin G; Mast Cells; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Receptors, IgE; Receptors, IgG; Serotonin | 2002 |
Modulation of antigen- and ischemia-induced effects by the platelet-activating factor antagonist WEB-2086 in isolated sensitized rat hearts.
Topics: Anaphylaxis; Animals; Antigens; Azepines; Chromatography, High Pressure Liquid; Chromones; Coronary Circulation; Heart; Histamine Release; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Platelet Activating Factor; Pressure; Rats; Rats, Wistar; Triazoles | 1992 |
Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection.
Topics: Anaphylaxis; Animals; Bronchoconstriction; Diterpenes; Female; Ginkgolides; Guinea Pigs; Histamine Release; Immunization, Secondary; In Vitro Techniques; Lactones; Lung; Male; Ovalbumin; Platelet Activating Factor; Thromboxane B2 | 1991 |
Interference of azelastine with anaphylaxis induced by ovalbumin challenge in actively sensitized rats.
Topics: Anaphylaxis; Animals; Azepines; Dihydropyridines; Dose-Response Relationship, Drug; Hematocrit; Histamine H1 Antagonists; Leukocyte Count; Male; Meclizine; Ovalbumin; Phthalazines; Platelet Activating Factor; Platelet Count; Rats; Rats, Inbred Strains; Terfenadine; Triazoles | 1992 |
Regulation of hepatic glycogenolysis and vasoconstriction during antigen-induced anaphylaxis.
Topics: Anaphylaxis; Animals; Antigens; Azepines; Eicosanoids; Epitopes; Female; Glycogen; Liver; Nitric Oxide; Ovalbumin; Platelet Activating Factor; Rats; Rats, Inbred Strains; Triazoles; Vasoconstriction | 1992 |
Platelet activating factor and systemic anaphylaxis in Nippostrongylus brasiliensis-sensitized rats: differential effects of PAF antagonists.
Topics: Anaphylaxis; Animals; Azepines; Blood Proteins; Diterpenes; Evans Blue; Ginkgolides; Hemodynamics; Lactones; Male; Microspheres; Nippostrongylus; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Triazoles | 1992 |
Inhibitory effect of NZ-107 on anaphylactic bronchoconstriction in guinea pigs and rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Anaphylaxis; Animals; Bronchoconstriction; Chromones; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Indomethacin; Injections, Intravenous; Male; Ovalbumin; Platelet Activating Factor; Propranolol; Prostaglandin Endoperoxides, Synthetic; Pyridazines; Pyrilamine; Rats; Rats, Inbred Strains; Regression Analysis; SRS-A | 1992 |
The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.
Topics: Anaphylaxis; Animals; Ascitic Fluid; Blood Pressure; Blood Proteins; Dinitrobenzenes; Immunoglobulin E; Leukotrienes; Lipids; Male; Peptides; Platelet Activating Factor; Rats; Rats, Inbred Strains; Serum Albumin, Bovine | 1992 |
Platelet-activating factor (PAF) plays an important role in the immediate asthmatic response in guinea-pig by augmenting the response to histamine.
Topics: Anaphylaxis; Animals; Asthma; Bronchi; Guinea Pigs; Histamine; Male; Ovalbumin; Platelet Activating Factor; Platelet Count; Pyridinium Compounds; Respiratory Function Tests; SRS-A; Thiazoles; Thiazolidines | 1992 |
Effect of PAF-acether antagonists on active anaphylactic mouse paw edema.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Acetophenones; Anaphylaxis; Animals; Aspirin; Azepines; Cimetidine; Dexamethasone; Edema; Male; Meclizine; Methysergide; Mice; Ovalbumin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prednisolone; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tetrazoles; Triazoles | 1991 |
Characterization of cardiovascular events mediated by platelet activating factor during systemic anaphylaxis.
Topics: Anaphylaxis; Animals; Arrhythmias, Cardiac; Azepines; Blood Pressure; Cardiac Output; Cimetidine; Electrocardiography; Female; Guinea Pigs; Heart Rate; Hemodynamics; Histamine; Male; Myocardial Contraction; Ovalbumin; Platelet Activating Factor; Pyrilamine; Triazoles | 1990 |
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Topics: Anaphylaxis; Animals; Azepines; Furans; Hemolysis; Humans; Hypotension; Isoquinolines; Male; Microsomes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Tetrahydroisoquinolines; Triazoles | 1992 |
A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat.
Topics: Anaphylaxis; Animals; Azepines; Biological Transport; Carbazoles; Dinoprostone; Electrolytes; Female; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Jejunum; Leukotriene Antagonists; Leukotrienes; Phospholipids; Platelet Activating Factor; Propionates; Quinolines; Rats; Thromboxanes; Triazoles | 1992 |
PAF induces rat plasma extravasation and releases eicosanoids during anaphylaxis.
Topics: Anaphylaxis; Animals; Blood Proteins; Capillary Permeability; Diterpenes; Eicosanoids; Ginkgolides; Indomethacin; Lactones; Male; Methysergide; Peritoneal Cavity; Platelet Activating Factor; Pyrilamine; Rats; Rats, Inbred Strains | 1991 |
Inhibitory effects of a novel PAF antagonist E6123 on anaphylactic responses in passively and actively sensitized guinea pigs and passively sensitized mice.
Topics: Administration, Inhalation; Anaphylaxis; Animals; Antigens; Asthma; Azepines; Guinea Pigs; Male; Mice; Mice, Inbred ICR; Ovalbumin; Platelet Activating Factor; Propranolol; Pyrilamine; Triazoles | 1991 |
A limited role for leukotrienes and platelet-activating factor in food protein induced jejunal smooth muscle contraction in sensitized rats.
Topics: Anaphylaxis; Animals; Dietary Proteins; Disease Models, Animal; Food Hypersensitivity; In Vitro Techniques; Jejunum; Leukotrienes; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats | 1991 |
Protective effect of SR 27417, a novel PAF antagonist, on lethal anaphylactic and endotoxin-induced shock in mice.
Topics: Anaphylaxis; Animals; Azepines; Dose-Response Relationship, Drug; Endotoxins; Escherichia coli; Male; Mice; Mice, Inbred Strains; Ovalbumin; Platelet Activating Factor; Shock, Septic; Thiazoles; Triazoles | 1991 |
Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs.
Topics: Anaphylaxis; Animals; Asthma; Bronchoconstriction; Disease Models, Animal; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Male; Ovalbumin; Platelet Activating Factor; Propranolol; Pyrilamine; SRS-A; Thiazoles; Thiazolidines | 1991 |
Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs.
Topics: Anaphylaxis; Animals; Azepines; Blood Pressure; Guinea Pigs; Lung; Male; Mice; Mice, Inbred Strains; Ovalbumin; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Propranolol; Pyrilamine; Respiration; Triazoles | 1991 |
Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains.
Topics: Anaphylaxis; Animals; Bordetella pertussis; Disease Susceptibility; Immunoglobulin G; Male; Mice; Mice, Inbred Strains; Phospholipid Ethers; Platelet Activating Factor; Serum Albumin, Bovine; Species Specificity | 1991 |
Inhibition of active anaphylaxis in mice and guinea pigs by the new hetrazepinoic PAF antagonist bepafant (WEB 2170).
Topics: Anaphylaxis; Animals; Azepines; Blood Pressure; Bronchoconstriction; Guinea Pigs; Immunization; Male; Mice; Ovalbumin; Platelet Activating Factor; Propranolol; Pulmonary Ventilation; Pyrilamine; Triazoles | 1991 |
[Allergy and PAF].
Topics: Anaphylaxis; Animals; Asthma; Humans; Leukocytes; Macrophages; Mast Cells; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Urticaria | 1991 |
Selective implication of thromboxane A2 and PAF-acether in two guinea pig anaphylactic models.
Topics: Anaphylaxis; Animals; Antigens; Glyceryl Ethers; Guinea Pigs; Immunoglobulin E; Immunoglobulin G; In Vitro Techniques; Indomethacin; Muscle Contraction; Platelet Activating Factor; Thiazoles; Thromboxane A2; Trachea | 1990 |
Effects of a novel PAF antagonist, E6123, on passive anaphylaxis.
Topics: Anaphylaxis; Animals; Antigens; Azepines; Bronchoconstriction; Guinea Pigs; Male; Mice; Mice, Inbred ICR; Platelet Activating Factor; Platelet Aggregation; Triazoles | 1990 |
Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor.
Topics: Anaphylaxis; Animals; Azepines; Blood Pressure; Bronchi; Female; Guinea Pigs; Hematocrit; Male; Mice; Mice, Inbred ICR; Platelet Activating Factor; Rats; Rats, Inbred Lew; Triazoles | 1990 |
Anaphylactic challenge causes eosinophil accumulation in bronchoalveolar lavage fluid of guinea pigs. Modulation by betamethasone, phenidone, indomethacin, WEB 2086, and a novel antiallergy agent, SCH 37224.
Topics: Albumins; Anaphylaxis; Animals; Asthma; Azepines; Betamethasone; Bronchoalveolar Lavage Fluid; Cell Count; Eosinophils; Guinea Pigs; Histamine; Immunization; Indomethacin; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung; Male; Naphthyridines; Ovalbumin; Platelet Activating Factor; Pyrazoles; Thromboxanes; Triazoles | 1990 |
Isolated coronary-perfused mammalian heart: assessment of eicosanoid and platelet-activating factor release and effects.
Topics: Anaphylaxis; Animals; Coronary Circulation; Coronary Vessels; Eicosanoids; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Models, Biological; Myocardial Contraction; Myocardial Reperfusion; Neutrophils; Perfusion; Platelet Activating Factor; Prostaglandins; Rabbits; Rats; Solutions; SRS-A | 1990 |
Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain.
Topics: Anaphylaxis; Animals; Cyproheptadine; Female; Histamine; Immunization, Passive; Mast Cells; Mice; Mice, Mutant Strains; Phospholipid Ethers; Platelet Activating Factor; Serotonin | 1990 |
The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.
Topics: Anaphylaxis; Animals; Azepines; Blood Cell Count; Bronchi; Enzyme-Linked Immunosorbent Assay; Guinea Pigs; Histamine; Immunization, Secondary; Immunoglobulin G; Lung; Ovalbumin; Platelet Activating Factor; Radioimmunoassay; Spectrometry, Fluorescence; Thromboxane B2; Triazoles | 1990 |
Effects of the PAF antagonist WEB 2086 on PAF-induced physiologic alterations and on IgE anaphylaxis in the rabbit.
Topics: Anaphylaxis; Animals; Azepines; Bronchial Spasm; Hypotension; Immunoglobulin E; Leukopenia; Lung; Platelet Activating Factor; Rabbits; Thrombocytopenia; Triazoles | 1990 |
[Effects of Hymenoptera stings: physiopathology and immunology according to recent literature findings].
Topics: Adolescent; Adult; Anaphylaxis; Bees; Child; Child, Preschool; Female; Histamine Release; Humans; Hymenoptera; Insect Bites and Stings; Kinins; Male; Platelet Activating Factor; Wasps | 1985 |
Studies of platelet activating factor (PAF) antagonists from microbial products. II. Pharmacological studies of FR-49175 in animal models.
Topics: Anaphylaxis; Animals; Blood Pressure; Bronchi; Capillary Permeability; Gliotoxin; Guinea Pigs; Male; Mice; Mycotoxins; Penicillium; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1986 |
[Developmental trends in allergologic-immunologic research].
Topics: Allergens; Anaphylaxis; Asthma; Blood Coagulation Factors; Bronchi; Cytoplasmic Granules; Histamine Release; Humans; Hypersensitivity; Immunoglobulin E; Mast Cells; Platelet Activating Factor; Prostaglandins; Receptors, Fc; Respiratory Hypersensitivity; SRS-A | 1986 |
Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig.
Topics: Airway Resistance; Anaphylaxis; Animals; Diterpenes; Female; Ginkgolides; Guinea Pigs; Histamine Release; In Vitro Techniques; Lactones; Lung; Male; Ovalbumin; Plant Extracts; Platelet Activating Factor; Thromboxane B2 | 1987 |
Interference of the PAF-acether antagonist BN 52021 with anaphylaxis in the guinea pig.
Topics: Anaphylaxis; Animals; Guinea Pigs; Histamine Release; In Vitro Techniques; Lung; Ovalbumin; Platelet Activating Factor | 1987 |
Interactions of platelet activating factor, thromboxane A2 and leukotrienes in guinea-pig heart.
Topics: Anaphylaxis; Animals; Azepines; Cyclooxygenase Inhibitors; Guinea Pigs; Heart; In Vitro Techniques; Indomethacin; Leukotrienes; Lipoxygenase Inhibitors; Naphthoquinones; ortho-Aminobenzoates; Platelet Activating Factor; Thromboxane A2; Triazines; Triazoles | 1989 |
Possible involvement of platelet activating factor in anaphylaxis of passively sensitised, isolated guinea pig hearts.
Topics: Anaphylaxis; Animals; Coronary Circulation; Diterpenes; Dose-Response Relationship, Drug; Ginkgolides; Guinea Pigs; Hemodynamics; Immunization, Passive; Lactones; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1989 |
The pathophysiological role of PAF in anaphylactic lung reaction in the guinea pig and in endotoxin shock evidenced by the specific PAF-antagonist WEB 2086.
Topics: Anaphylaxis; Animals; Antigens; Azepines; Disease Models, Animal; Endotoxins; Escherichia coli; Guinea Pigs; Lung Diseases; Ovalbumin; Platelet Activating Factor; Pyrilamine; Shock, Septic; Triazines; Triazoles | 1989 |
[Renal diseases and platelet activating factor].
Topics: Acute Kidney Injury; Anaphylaxis; Animals; Cyclosporins; Diterpenes; Ginkgolides; Glomerulonephritis; Graft Rejection; Kidney Diseases; Lactones; Plant Extracts; Platelet Activating Factor; Proteinuria; Rabbits; Rats | 1989 |
Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models.
Topics: Anaphylaxis; Animals; Aspirin; Diterpenes; Fatty Acids, Unsaturated; Female; Ginkgolides; Imidazoles; Ketotifen; Lactones; Masoprocol; Mice; Naphthalenes; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock; Shock, Septic | 1989 |
Anaphylactic release of platelet activating factor acether and eicosanoids from lungs of guinea pigs sensitized to ovalbumin aerosol.
Topics: Anaphylaxis; Animals; Fatty Acids, Unsaturated; Guinea Pigs; Leukotriene B4; Lung; Male; Ovalbumin; Platelet Activating Factor; SRS-A; Thromboxane B2 | 1987 |
Inhibition of the release of prostaglandins, thromboxanes, and leukotrienes from anaphylactic lungs by a platelet-activating factor (PAF) antagonist and its stimulation by PAF.
Topics: 6-Ketoprostaglandin F1 alpha; Anaphylaxis; Animals; Dinoprostone; Fatty Acids, Unsaturated; Guinea Pigs; In Vitro Techniques; Leukotriene B4; Lung; Platelet Activating Factor; Prostaglandins E; SRS-A; Thromboxane B2 | 1987 |
Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021.
Topics: Anaphylaxis; Animals; Bronchial Spasm; Diterpenes; Ginkgolides; Guinea Pigs; In Vitro Techniques; Lactones; Lung; Male; Plant Extracts; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1986 |
[IgE and anaphylaxis mediators].
Topics: Anaphylaxis; Animals; Humans; Immunity, Cellular; Immunoglobulin E; Platelet Activating Factor; Receptors, Fc; Receptors, IgE | 1987 |
Antiinflammatory and antiallergic effects of a novel metabolite of Nocardiopsis sp. as a potent protein kinase C inhibitor from microbial origin.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Arthus Reaction; Bronchi; Carbazoles; Guinea Pigs; Hypersensitivity; Indole Alkaloids; Male; Mice; Nocardiaceae; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Protein Kinase C; Rabbits; Rats | 1988 |
[Mediators of immediate anaphylactic reactions].
Topics: Anaphylaxis; Chemotactic Factors; Enzymes; Histamine; Humans; Leukotriene B4; Platelet Activating Factor; Prostaglandins; Proteoglycans; SRS-A | 1985 |
Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock.
Topics: Anaphylaxis; Animals; Blood Platelets; Hypotension; Mice; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Thiazoles | 1985 |
Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
Topics: Anaphylaxis; Animals; Antigen-Antibody Complex; Capillary Permeability; Female; Furans; Hydrolases; Hypotension; Kinetics; Liver; Lysosomes; Neutropenia; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1986 |
Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists.
Topics: Alprazolam; Anaphylaxis; Animals; Benzodiazepines; Benzofurans; Benzopyrans; Diphenhydramine; Guinea Pigs; Histamine; Lignans; Male; Muscle Contraction; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; SRS-A | 1986 |
Chemical mediators of anaphylaxis released by alveolar macrophages in bronchial asthma.
Topics: Anaphylaxis; Arachidonic Acid; Arachidonic Acids; Asthma; Blood Proteins; Humans; Leukotriene B4; Macrophages; Platelet Activating Factor; Pulmonary Alveoli | 1986 |
Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Alprazolam; Anaphylaxis; Animals; Anti-Inflammatory Agents; Benzodiazepines; Blood Pressure; Diphenhydramine; Guinea Pigs; In Vitro Techniques; Kinetics; Lung; Male; Ovalbumin; Platelet Activating Factor; Platelet Count; Pyrazoles | 1986 |
Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
Topics: Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Dinoprostone; Diterpenes; Female; Ginkgolides; Guinea Pigs; In Vitro Techniques; Kinetics; Lactones; Lung; Male; Ovalbumin; Plant Extracts; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Thromboxane B2; Thromboxanes | 1986 |
Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
Topics: Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Blood Pressure; Diterpenes; Dose-Response Relationship, Drug; Ginkgolides; Guinea Pigs; Lactones; Lung; Male; Perfusion; Plant Extracts; Platelet Activating Factor; Thromboxane B2 | 1986 |
A lethal role of platelet activating factor in anaphylactic shock in mice.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chromones; Dexamethasone; Male; Mice; Mice, Inbred Strains; Naloxone; Phospholipid Ethers; Platelet Activating Factor; Pyrazoles; SRS-A; Thiazoles | 1987 |
Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anaphylaxis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Blood Pressure; Diphenhydramine; Guinea Pigs; In Vitro Techniques; Lignans; Lung; Male; Platelet Activating Factor; Platelet Count; Pyrazoles | 1987 |
Platelet-activating factor in the inflammatory exudate in the anaphylactic phase of allergic inflammation in rats.
Topics: Adenosine Diphosphate; Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Chromatography, High Pressure Liquid; Exudates and Transudates; Inflammation; Male; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred Strains; Thiazoles | 1987 |
Platelet-activating factor and the cardiovascular system: involvement in cardiac anaphylaxis.
Topics: Anaphylaxis; Animals; Arachidonic Acid; Arachidonic Acids; Guinea Pigs; Heart; Male; Platelet Activating Factor; Vasoconstriction | 1988 |
Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models.
Topics: Anaphylaxis; Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; Lipoxygenase Inhibitors; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock, Septic | 1988 |
Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis.
Topics: Anaphylaxis; Animals; Blood Cells; Blood Platelets; Bronchi; Furans; Guinea Pigs; Hematocrit; Leukocytes; Male; Phospholipid Ethers; Platelet Activating Factor | 1988 |
BN-52021 protects guinea-pig from heart anaphylaxis.
Topics: Anaphylaxis; Animals; Diterpenes; Ginkgolides; Guinea Pigs; Heart; Heart Rate; Histamine; Lactones; Male; Platelet Activating Factor; Thromboxane B2 | 1988 |
Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge.
Topics: Administration, Inhalation; Anaphylaxis; Animals; Azepines; Blood Pressure; Guinea Pigs; Injections, Intravenous; Lung; Platelet Activating Factor; Triazines; Triazoles | 1988 |
Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
Topics: Allergens; Anaphylaxis; Animals; Antigens; Blood Platelets; Bronchi; Eosinophils; Epoprostenol; Female; Guinea Pigs; Lung; Male; Mucous Membrane; Platelet Activating Factor; Platelet Count | 1988 |
Involvement of PAF-acether in anaphylactic bronchoconstriction induced in guinea pigs by aerosolized antigen.
Topics: Aerosols; Anaphylaxis; Animals; Antigens; Bronchial Spasm; Chromones; Desensitization, Immunologic; Female; Guinea Pigs; Histamine; Male; Ovalbumin; Platelet Activating Factor; Pyrilamine; Time Factors | 1988 |
New pharmacological data on the bronchospasmolytic activity of bamifylline.
Topics: Acetylcholine; Airway Resistance; Anaphylaxis; Animals; Bronchodilator Agents; Guinea Pigs; Histamine; Male; Platelet Activating Factor; SRS-A; Theophylline; Thromboxane A2 | 1988 |
Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion.
Topics: Anaphylaxis; Animals; Blood Platelets; Bronchial Spasm; Female; Granulocytes; Guinea Pigs; Lung; Male; Microscopy, Electron; Platelet Activating Factor; Pyrilamine; Vasoconstriction | 1987 |
Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis.
Topics: Administration, Oral; Anaphylaxis; Animals; Azepines; Blood Pressure; Guinea Pigs; Immunization; Immunization, Passive; Injections, Intravenous; Male; Mice; Ovalbumin; Platelet Activating Factor; Pyrilamine; Respiration; Triazines; Triazoles | 1987 |
Ontogeny of the responsiveness to intravenous platelet-activating factor.
Topics: Aging; Anaphylaxis; Animals; Animals, Newborn; Female; Leukopenia; Lung; Male; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Rabbits; Thrombocytopenia; Thromboxane B2 | 1987 |
Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs.
Topics: Anaphylaxis; Animals; Azepines; Female; Guinea Pigs; Histamine; In Vitro Techniques; Indicators and Reagents; Leukopenia; Male; Passive Cutaneous Anaphylaxis; Platelet Activating Factor; Radioimmunoassay; Respiratory System; Spectrometry, Fluorescence; Thrombocytopenia; Thromboxane B2; Triazines; Triazoles | 1987 |
The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
Topics: Anaphylaxis; Animals; Guinea Pigs; In Vitro Techniques; Lung; Male; Perfusion; Platelet Activating Factor; Pulmonary Circulation; Time Factors | 1986 |
Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
Topics: Anaphylaxis; Animals; Bronchi; Chromones; Diterpenes; Ginkgolides; Guinea Pigs; Lactones; Male; Plant Extracts; Platelet Activating Factor | 1986 |
Use of steroidal antiinflammatory drug provides further evidence for a potential role of PAF-acether in bronchial anaphylaxis.
Topics: Anaphylaxis; Animals; Bronchi; Budesonide; Guinea Pigs; Immunoglobulin E; In Vitro Techniques; Platelet Activating Factor; Pregnenediones | 1986 |
A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction.
Topics: Aerosols; Anaphylaxis; Animals; Blood Platelets; Diterpenes; Female; Ginkgolides; Guinea Pigs; Immunoglobulin E; Lactones; Male; Neutrophils; Ovalbumin; Plant Extracts; Platelet Activating Factor; Propranolol | 1986 |
PAF-acether and leukotriene participation in acute circulatory shock.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Dogs; Guinea Pigs; Hemodynamics; Male; Mice; Microcirculation; Platelet Activating Factor; Regional Blood Flow; Shock; Shock, Hemorrhagic; Shock, Septic; SRS-A | 1986 |
Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021.
Topics: Anaphylaxis; Animals; Bronchi; Diterpenes; Ginkgolides; Guinea Pigs; Lactones; Plant Extracts; Platelet Activating Factor; Propranolol; Pyrilamine; Thrombocytopenia | 1986 |
Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs.
Topics: Anaphylaxis; Animals; Blood Pressure; Diterpenes; Ginkgolides; Heart; Heart Rate; In Vitro Techniques; Lactones; Myocardial Contraction; Plant Extracts; Platelet Activating Factor; Rabbits | 1986 |
Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.
Topics: Anaphylaxis; Animals; Capillary Permeability; Diterpenes; Ginkgolides; Hypotension; Immunoglobulin G; Lactones; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1985 |
Participation of platelets in the physiologic alterations of the AGEPC response and of IgE anaphylaxis in the rabbit. Effects of PGI2 inhibition of platelet function.
Topics: Anaphylaxis; Animals; Antigens; Blood Platelets; Chlorpheniramine; Epoprostenol; Female; Immunoglobulin E; Male; Platelet Activating Factor; Rabbits | 1985 |
Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.
Topics: Acetophenones; Anaphylaxis; Animals; Catechols; Chromones; Female; Guinea Pigs; Histamine; In Vitro Techniques; Lung; Male; Masoprocol; Muscle Contraction; Platelet Activating Factor; SRS-A | 1985 |
Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse.
Topics: Anaphylaxis; Animals; Chloroquine; Chlortetracycline; Dexamethasone; Dose-Response Relationship, Drug; Female; Indomethacin; Injections, Intravenous; Male; Mice; Mice, Inbred DBA; Naproxen; Nicardipine; Nifedipine; Platelet Activating Factor; Pyrazoles; Quinacrine; Tetracycline; Verapamil | 1985 |